Belite Bio, Inc (BLTE)

USD 58.61

(3.55%)

Annual Cash Flows

(In USD)
Breakdown 2023 2022 2021 2020
Operating Cash Flow -29.83 Million -11.45 Million -7.47 Million -4.44 Million
Net Income -31.63 Million -12.64 Million -9.66 Million -5.75 Million
Depreciation & Amortization 399 Thousand 198 Thousand 30 Thousand 17 Thousand
Deferred income taxes -4.69 Million -1.91 Million - -1.39 Million
Stock-based compensation 3.82 Million 1.48 Million 1.53 Million 1.36 Million
Change in working capital -2.42 Million -491 Thousand 640 Thousand -69 Thousand
Other non-cash items 4.69 Million 1.91 Million -8000.00 1.39 Million
Investing Cash Flow -63 Thousand -394 Thousand -56 Thousand -20 Thousand
Investments in PPE -63 Thousand -394 Thousand -74 Thousand -20 Thousand
Acquisitions - - 18 Thousand -
Investment purchases - - - -
Sales/Maturities of investments - - - -
Other Investing Activities - -394 Thousand 18 Thousand -
Financing Cash Flow 75.95 Million 36.96 Million -583 Thousand 28.05 Million
Debt repayment - - - -2.45 Million
Dividends payments - - - -
Common Stock Repurchased - - - -
Common Stock Issuance 77.18 Million 36.96 Million -583 Thousand 500 Thousand
Other Financing Activities -1.23 Million -1.03 Million -815 Thousand 30 Million
Accounts receivables -72 Thousand -32 Thousand - 4000.00
Accounts payables - - - -
Inventory - - - -
Other working capital -2.35 Million -459 Thousand 640 Thousand -73 Thousand
Cash at beginning of period 42.08 Million 17.34 Million 25.61 Million 2.01 Million
Cash at end of period 88.15 Million 42.08 Million 17.34 Million 25.61 Million
Capital Expenditure -63 Thousand -394 Thousand -74 Thousand -20 Thousand
Effect of forex changes on cash 9000.00 -366 Thousand -161 Thousand 4000.00
Net cash flow / Change in cash 46.06 Million 24.74 Million -8.27 Million 23.6 Million
Free Cash Flow -29.9 Million -11.85 Million -7.54 Million -4.46 Million

Cash Flow Charts